Regulation 2022/2370 - Amendment of Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
Contents
official title
Regulation (EU) 2022/2370 of the European Parliament and of the Council of 23 November 2022 amending Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control| Legal instrument | Regulation |
|---|---|
| Number legal act | Regulation 2022/2370 |
| Original proposal | COM(2020)726  |
| CELEX number i | 32022R2370 |
| Document | 23-11-2022; Date of signature |
|---|---|
| Publication in Official Journal | 06-12-2022; OJ L 314 p. 1-25 |
| Signature | 23-11-2022 |
| Effect | 26-12-2022; Entry into force Date pub. +20 See Art 2 |
| End of validity | 31-12-9999 |
6.12.2022 |
EN |
Official Journal of the European Union |
L 314/1 |
REGULATION (EU) 2022/2370 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 23 November 2022
amending Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 168(5) thereof,
Having regard to the proposal from the European Commission,
After transmission of the draft legislative act to the national parliaments,
Having regard to the opinion of the European Economic and Social Committee (1),
Having regard to the opinion of the Committee of the Regions (2),
Acting in accordance with the ordinary legislative procedure (3),
Whereas:
(1) |
The Union is committed as a priority to protecting and improving human health through the prevention of disease and by fighting against major cross-border health scourges by means of monitoring, assessing, communicating on, improving preparedness for, providing early warning of and combatting serious cross-border threats to health. |
(2) |
The European Centre for Disease Prevention and Control (the ‘Centre’) was established by Regulation (EC) No 851/2004 of the European Parliament and of the Council (4) as an independent European agency with the mission to identify, assess and communicate current and emerging threats to human health from communicable diseases. |
(3) |
On 11 March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic. Given the challenges experienced in responding to the pandemic, it became clear that the Union’s framework for health crisis preparedness and response should be strengthened to better use the potential of the Union’s and Member States’ capacities to respond to future pandemics. |
(4) |
In its decision of 5 February 2021 in strategic inquiry OI/3/2020/TE, the European Ombudsman identified some important gaps in the effectiveness of the Centre’s response to the COVID-19 pandemic, such as regarding complete and comparable data, the level of transparency and communications to the public. Those shortcomings should be addressed in this Regulation. |
(5) |
The capacity of the Centre to implement new tasks will depend on the level of financial assistance available from the Union, as well as on the internal and external human resources available. In order to be able to fulfil the new tasks entrusted to it as a result of the COVID-19 pandemic, the Centre will need sufficient funding and staffing. Project-oriented funds, such as those allocated under the EU4Health Programme, established by Regulation (EU) 2021/522 of the European Parliament and of the Council (5), are not sufficient to respond to the Centre’s needs in the future. |
(6) |
The overexploitation of wildlife and other natural resources and the accelerated loss of biodiversity pose a risk to human health. As the health of humans, animals and the environment are inextricably linked, it is crucial to follow the ‘One Health’ approach to addressing current and emerging crises. |
(7) |
In their joint opinion ‘Improving pandemic preparedness and management’, the Group of Chief Scientific Advisors to the Commission, the European Group on Ethics in Science and New Technologies and the Special Advisor to the President of the Commission on the response to COVID-19 recommend establishing ‘a standing EU advisory body for health threats and crises’. |
(8) |
This Regulation should therefore expand the mission and tasks of the Centre in order to enhance the Centre’s capacity to provide the required robust and independent scientific expertise, and to support actions which are relevant to the prevention, preparedness and response... |
More
This text has been adopted from EUR-Lex.
This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.
This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.